Reducing the Risk of ADHD
Learn valuable insights into reducing the risk of attention-deficit/hyperactivity disorder (ADHD) with a combination of behavioral interventions (PTBM) and FDA-approved medications.
About this course
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder that has been diagnosed in up to 10% of school-age children in the US and frequently persists into adulthood. A study in a large Danish cohort found that ADHD was associated with higher mortality rates in children, adolescents, and adults, mainly due to accidents. Pharmacologic treatment of ADHD in children has been reported to decrease the risk of substance abuse in adolescents, and use of ADHD medications in adults has been associated with a reduced risk of serious traffic accidents and criminal behavior. This activity discusses how to reduce the risk of ADHD with PTBM and drugs approved by the FDA for treatment of ADHD.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection